Transplant Immunosuppression Molecular Monitoring Market

The type assays segment leads the transplant immunosuppression molecular monitoring market by product with a 39.1% share in 2026. PCR-based monitoring accounts for 41.1% by technology, kidney transplant represents 44.2% by transplant type, and hospitals & transplant centers lead the end-user segment with 43.1%.